Schedule of Changes in Shares Issued and Outstanding |
Changes in OMH shares of common stock issued and outstanding were as follows: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, | | Six Months Ended June 30, | | | | | 2025 | | 2024 | | 2025 | | 2024 | | | | | | | | | | | | | | Balance at beginning of period | | 119,281,560 | | | 119,877,252 | | | 119,360,509 | | | 119,757,277 | | | | Common stock issued | | 15,470 | | | 11,572 | | | 239,384 | | | 223,274 | | | | Common stock repurchased | | (459,597) | | | (151,538) | | | (782,773) | | | (260,223) | | | | Treasury stock issued | | 19,555 | | | 20,805 | | | 39,868 | | | 37,763 | | | | | | | | | | | | | | | Balance at end of period | | 118,856,988 | | | 119,758,091 | | | 118,856,988 | | | 119,758,091 | | | |
|
Schedule of Computation of Earnings Per Share |
The computation of earnings per share was as follows: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, | | Six Months Ended June 30, 2025 | | | (dollars in millions, except per share data) | | 2025 | | 2024 | | 2025 | | 2024 | | | | | | | | | | | | | | Numerator (basic and diluted): | | | | | | | | | | | Net income | | $ | 167 | | | $ | 71 | | | $ | 380 | | | $ | 225 | | | | Denominator: | | | | | | | | | | | Weighted average number of shares outstanding (basic) | | 118,953,510 | | | 119,787,550 | | | 119,176,259 | | | 119,808,362 | | | | Effect of dilutive securities * | | 439,309 | | | 397,631 | | | 505,007 | | | 406,563 | | | | Weighted average number of shares outstanding (diluted) | | 119,392,819 | | | 120,185,181 | | | 119,681,266 | | | 120,214,925 | | | | Earnings per share: | | | | | | | | | | | Basic | | $ | 1.40 | | | $ | 0.59 | | | $ | 3.19 | | | $ | 1.88 | | | | Diluted | | $ | 1.40 | | | $ | 0.59 | | | $ | 3.18 | | | $ | 1.87 | | | |
* We have excluded weighted-average unvested restricted stock units totaling 920,270 and 706,042 for the three months ended June 30, 2025 and 2024, respectively, and 838,208 and 701,837 for the six months ended June 30, 2025 and 2024, respectively, from the fully-diluted earnings per share calculations as these shares would be anti-dilutive, which could impact the earnings per share calculation in the future.
|